tiprankstipranks
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market

Neurosense Therapeutics Ltd. (NRSN) Financial Statements

Compare
130 Followers

Neurosense Therapeutics Ltd. Financial Overview

Neurosense Therapeutics Ltd.'s market cap is currently $25.73M. The company's EPS TTM is $-0.698; its P/E ratio is ―; Neurosense Therapeutics Ltd. is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -97.00K$ -89.00K--$ 0.00
Operating Income$ -12.05M$ -13.55M$ -5.59M$ -2.89M$ -1.24M
EBITDA$ -10.63M$ -13.38M$ -2.88M$ -2.83M$ -1.25M
Net Income$ -10.11M$ -11.20M$ -2.50M$ -2.83M$ -1.23M
Balance Sheet
Cash & Short-Term Investments$ 2.64M$ 7.09M$ 11.06M$ 699.00K$ 895.00K
Total Assets$ 3.18M$ 7.71M$ 11.43M$ 779.00K$ 955.00K
Total Debt$ 142.00K$ 211.00K$ 1.83M$ 0.00$ 0.00
Net Debt$ -2.50M$ -3.33M$ -9.23M$ -699.00K$ -895.00K
Total Liabilities$ 5.05M$ 2.09M$ 2.42M$ 120.00K$ 37.00K
Stockholders' Equity$ -1.87M$ 5.62M$ 9.01M$ 659.00K$ 918.00K
Cash Flow
Free Cash Flow$ -8.48M$ -7.66M$ -1.56M$ -704.00K$ -589.00K
Operating Cash Flow$ -8.45M$ -7.59M$ -1.54M$ -695.00K$ -582.00K
Investing Cash Flow$ 3.47M$ -3.54M$ -17.00K$ -9.00K$ -26.00K
Financing Cash Flow$ 3.90M$ 3.69M$ 11.90M$ 508.00K$ 1.42M
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History

Neurosense Therapeutics Ltd. Debt to Assets

Neurosense Therapeutics Ltd. Cash Flow

Neurosense Therapeutics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis